FDA Allows for First Point-of-Care Chlamydia and Gonorrhea Test to be Used in More Near-Patient Care Settings

Today, the U.S. Food and Drug Administration announced it is allowing the use of the Binx Health IO CT/NG Assay at point-of-care settings, such as in physician offices, community-based clinics, urgent care settings, outpatient health care facilities and other patient care settings, operating under a CLIA Certificate of Waiver, Certificate of Compliance or Certificate of […]
FDA Approves New indication for Drug to Treat Neurogenic Detrusor Overactivity in Pediatric Patients

Today, the U.S. Food and Drug Administration approved a new indication for Myrbetriq (mirabegron extended-release tablets) and Myrbetriq Granules (mirabegron for extended-release oral suspension) to treat neurogenic detrusor overactivity (NDO), a bladder dysfunction related to neurological impairment, in children ages three years and older. Myrbetriq is also indicated for overactive bladder in adult patients. “Today’s […]
FDA Warns Companies Illegally Selling Over-the-Counter CBD Products for Pain Relief

Products Listing CBD as Inactive Ingredient Cited for Unapproved Drug and Misbranding Violations The U.S. Food and Drug Administration has issued warning letters to two companies for selling products labeled as containing cannabidiol (CBD) in ways that violate the Federal Food, Drug, and Cosmetic Act (FD&C Act). Specifically, the warning letters address the illegal marketing […]
#Vaccinate4Love – Grassroots Public Awareness Campaign Launches to Help Overcome Covid-19 Vaccine Hesitancy

1,200 of America’s Top Doctors Sign On – “Don’t Hesitate. Vaccinate.”
FDA Statement on Vaccines and Related Biological Products Advisory Committee Meeting

The following is attributed to Acting Commissioner Janet Woodcock, M.D. and Peter Marks, M.D., Ph.D., director of the FDA’s Center for Biologics Evaluation and Research Following today’s positive advisory committee meeting outcome regarding the Janssen Biotech Inc. COVID-19 Vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward […]
Pandemic adding to the physical and financial stress facing many Black caregivers

While the risk of COVID-19 poses the greatest threat to the elderly, it’s also taking a toll on the people they rely on most: their caregivers. This is particularly true in the Black community, where the pandemic presents new sources of stress, both physically and financially. A new Nationwide Retirement Institute® survey of 313 Black […]
Moments in History: Patricia Bath

Patricia Era Bath (November 4, 1942 – May 30, 2019) was an American ophthalmologist, inventor, humanitarian, and academic. She was an early pioneer of laser cataract surgery. She also became first woman member of the Jules Stein Eye Institute, first woman to lead a post-graduate training program in ophthalmology, and first woman elected to the honorary staff of […]
Black History Month and Cancer Care

Since 1976, the month of February has been designated as Black History Month in the United States. The month provides an opportunity to celebrate the many contributions African Americans have made to the country’s history while recognizing inequities and struggles that have divided the nation over the course of time. Inequality has spanned across every inch […]
FDA Approves First Extended-Release, Injectable Drug Regimen for Adults Living with HIV

The U.S. Food and Drug Administration approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults to replace a current antiretroviral regimen in those who are virologically suppressed on a stable antiretroviral regimen with no history of treatment failure and with […]
Coronavirus (COVID-19) Update: January 22, 2021

The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA’s Office of Criminal Investigations recently investigated a case that has led to an arrest and the filing of a criminal complaint by the U.S. Department of Justice for introducing misbranded drugs into interstate commerce. […]
